Dr. Gower is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2020 Santa Monica Blvd Suite 230
Santa Monica, CA 90404Phone+1 310-829-5471Fax+1 310-829-6192
Summary
- Arjan Gower, MD is a hematologist and oncologist based in Los Angeles, California, with a focus in Thoracic and Breast Cancer. He has an MS in Tumor Biology from Georgetown University School of Medicine and MD from Chicago Medical School. He completed his residency in Internal Medicine at Cedars-Sinai Medical Center and fellowship in Hematology and Medical Oncology at UCLA Medical Center. Dr. Gower has published multiple research findings in renowned medical publications such as Nature, Translational Cancer Research, and Molecular Oncology, and was recognized with the Rubenstein Research of the Year Award from Cedars-Sinai Medical Center in 2021. He sees a variety of patients in addition to conducting lung cancer research.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2021 - 2024
- Cedars-Sinai Medical CenterResidency, Internal Medicine, 2018 - 2021
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2018, MD
- Georgetown University Medicine CenterMS, Tumor Biology
Certifications & Licensure
- CA State Medical License 2019 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Rubenstein Research of the Year Award Cedars-Sinai Medical Center, 2021
Publications & Presentations
PubMed
- 10 citationsComprehensive tissue deconvolution of cell-free DNA by deep learning for disease diagnosis and monitoring.Shuo Li, Weihua Zeng, Xiaohui Ni, Qiao Liu, Wenyuan Li
Proceedings of the National Academy of Sciences of the United States of America. 2023-07-11 - 52 citationsOncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancerArjan Gower, Yisong Wang, Giuseppe Giaccone
Journal of Molecular Medicine. 2014-05-23 - 8 citationsCRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma.Rong An, Yisong Wang, Donna Voeller, Arjan Gower, In-Kyu Kim
Oncotarget. 2016-04-07
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: